Literature DB >> 10678616

Asthma management in five European countries: doctors' knowledge, attitudes and prescribing behaviour. Drug Education Project (DEP) group.

P Lagerløv1, C C Veninga, M Muskova, E Hummers-Pradier, C Stålsby Lundborg, M Andrew, F M Haaijer-Ruskamp.   

Abstract

The aim of the study was to examine the relationship between guideline recommendations on asthma management, and the performance of doctors in five different European health care contexts. Knowledge, attitudes and prescribing behaviour of doctors recruited to an educational project was investigated. A total of 698 general practitioners from Germany, The Netherlands, Norway and Sweden, and 94 specialists from the Slovak Republic participated. A questionnaire was used to assess their knowledge and attitudes. Antiasthmatic drugs dispensed to their patients reflected their prescribing behaviour. In response to questions on how to treat chronic asthma, most doctors were in agreement with guideline recommendations. In practice, however, the proportion of asthma patients receiving inhaled steroids varied almost twofold, ranging 31% in Germany to 58% in The Netherlands. On questions related to exacerbation of asthma, German and Slovakian doctors often preferred treatment with antibiotics to steroids. They also more often associated yellow-green sputum with bacterial infection. In conclusion, although many doctors in different health care contexts have accepted the recommendations given in guidelines, the proportion of their patients treated accordingly differed. German and Slovakian doctors seem to attach less importance to the inflammatory features of asthma than the doctors from the other three European countries.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10678616

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  20 in total

1.  The predictive value of asthma medications to identify individuals with asthma--a study in German general practices.

Authors:  W Himmel; E Hummers-Pradier; H Schümann; M M Kochen
Journal:  Br J Gen Pract       Date:  2001-11       Impact factor: 5.386

2.  Anti-asthmatic drugs and dosage forms in children: a cross-sectional study.

Authors:  Eric Schirm; Hilde Tobi; Henkjan Gebben; Lolkje T W de Jong-van den Berg
Journal:  Pharm World Sci       Date:  2002-08

3.  General practitioners' ranking of evidence-based prescribing quality indicators: a comparative study with a prescription database.

Authors:  Ifeanyi Okechukwu; Kathleen Bennett; John Feely
Journal:  Br J Clin Pharmacol       Date:  2006-08       Impact factor: 4.335

4.  Contraindication labelling changes in the United States and Germany.

Authors:  Edeltraut Garbe; Frank Andersohn
Journal:  Eur J Clin Pharmacol       Date:  2006-11-24       Impact factor: 2.953

Review 5.  Montelukast: a review of its therapeutic potential in persistent asthma.

Authors:  B Jarvis; A Markham
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

6.  The cultivation of esteem and retrieval of scientific knowledge in physician networks.

Authors:  Daniel A Menchik; David O Meltzer
Journal:  J Health Soc Behav       Date:  2010-06

7.  The impact of guidelines on long-term asthma care: a study of hospitalised patients in Malta.

Authors:  Antonella Tonna; Dorothy J McCaig; Joseph M Cacciottolo
Journal:  Pharm World Sci       Date:  2004-08

8.  Necessary alternatives: patients' views of asthma treatment.

Authors:  Helen Kopnina; Joke Haafkens
Journal:  Patient Prefer Adherence       Date:  2010-06-24       Impact factor: 2.711

9.  Management of acute asthma exacerbations by general practitioners: a cross-sectional observational survey.

Authors:  Lydia Guittet; Carol J Blaisdell; Jocelyne Just; Lise Rosencher; Alain-Jacques Valleron; Antoine Flahault
Journal:  Br J Gen Pract       Date:  2004-10       Impact factor: 5.386

10.  Impact of a short postgraduate course in rational pharmacotherapy for general practitioners.

Authors:  Ahmet Akici; Sibel Kalaça; M Umit Ugurlu; Atila Karaalp; Sanda Cali; Sule Oktay
Journal:  Br J Clin Pharmacol       Date:  2004-03       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.